age and sex, were analyzed with the use of Poisson regression models (see the Supplementary Appendix).
The analysis suggests that changes in the reported incidence of ZIKV disease during 2015 and early 2016 were closely associated with changes in the incidence of the Guillain-Barré syndrome. During the weeks of ZIKV transmission, there were significant increases in the incidence of the Guillain-Barré syndrome, as compared with the pre-ZIKV baseline incidence, in Bahia State (an increase of 172%), Colombia (211%), the Dominican Republic (150%), El Salvador (100%), Honduras (144%), Suriname (400%), and Venezuela (877%) ( Table 1) . When the incidence of ZIKV disease increased, so did the incidence of the Guillain-Barré syndrome (Fig. 1A) . In the six countries that also reported decreases in the incidence of ZIKV disease, the incidence of the Guillain-Barré syndrome also declined. When the seven epidemics of ZIKV disease are aligned according to week of peak incidence, the total number of cases of ZIKV disease and the Guillain-Barré syndrome are closely coincident (Fig. 1B) , although the period from acquiring infection to reporting disease is approximately 2 weeks longer for ZIKV than for the GuillainBarré syndrome, a pattern that is especially visible in data from Colombia and Venezuela. Whether the 2-week difference can be explained in terms of incubation periods or reporting delays is not yet known. We explored the potential effect of dengue virus circulation on the incidence of the Guillain-Barré syndrome and found no link (see the Supplementary Appendix). In any event, we infer from these two series of cases, which were collected independently of each other, that ZIKV infection and the Guillain-Barré syndrome are strongly associated. Additional studies are needed to show that ZIKV infection is a cause of the Guillain-Barré syndrome.
Overall, females had a 75% higher reported incidence rate of ZIKV disease than did males (rate ratio, 1.75; 95% confidence interval [CI], 1.71 to 1.79); the rate was especially high among women 20 to 49 years of age (see the Supplementary Appendix). This difference was also observed in the Yap Island (Micronesia) epidemic 1 and could be due to greater exposure to the intradomiciliary mosquito vector, to more severe symptoms among women in this age group, to active health care-seeking behavior by females, or to enhanced reporting by health workers, given the risk of infection during pregnancy. However, the greater apparent risk of ZIKV disease among women 20 to 49 years of age was not matched by a similarly higher incidence of the Guillain-Barré syndrome, which may indicate an age and sex bias in the reporting of ZIKV disease. The reported incidence of the GuillainBarré syndrome was 28% higher among males than among females (rate ratio, 1.28; 95% CI, 1.09 to 1.50) and consistently increased with age, findings that are in line with previous reports.
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Approximately 500 million people in Latin America and the Caribbean are at risk for ZIKV infection, because they live in areas that are less than 2000 m above sea level where competent aedes vectors also are found. It is clear that increases in the incidence of the Guillain-Barré syndrome to a level that is 2.0 and 9.8 times as high as baseline, as we have reported here, impose a substantial burden on populations and health services in this region. Reports of the Guillain-Barré syndrome could serve as a sentinel for ZIKV disease and other neurologic disorders linked to ZIKV, including microcephaly. 
Guillain-Barré syndrome
Data for GBS are publically available for all states in Brazil via the Universal Health System online record of hospital discharges. 2 In the context of the ZIKV epidemic, Colombia, the Dominican Republic, El
Salvador, Honduras, Suriname, and Venezuela have provided data on GBS through IHR channels. In the seven countries included in the study, GBS was not a notifiable condition for weekly reporting, therefore there is an unspecified delay involved in collecting data at the national level. Even though timeliness of reporting is affected by this delay, notifications are made by date of onset of symptoms, so they can be attributed retroactively to the epidemiological week when they occurred.
Case definitions for GBS used by countries in the Americas are based on the criteria outlined by the Brighton collaboration. 3 In the context of ZIKV transmission, however, reporting for GBS has been reviewed and revised in many countries. In the absence of established surveillance protocols specifically for Zika-associated GBS, data from the countries were slightly different, but all data sets included the total number of GBS cases detected. For all the countries included in this analysis, between 25% and 75% of GBS cases presented signs and symptoms compatible with Zika virus disease. In each country, at least one case of GBS was confirmed by laboratory means as having ZIKV infection since the introduction of the virus. The detection of cases of GBS per 1,000 cases of Zika virus disease detected by surveillance ranged from 4.1 (in Honduras) to 31.8 (in the Dominican Republic).
Statistical Analysis
Cases of GBS and Zika virus disease per 100,000 population for the countries were calculated using the number of incident cases of GBS and Zika virus disease during the period of Zika virus circulation as the numerator and the annual mid-period population by age and sex (provided by the United Nations Population Division) as denominator. 4 We obtained baseline values for GBS incidence in each country by averaging observed rates of GBS in the years preceding the introduction of ZIKV. For countries (Dominican Republic and Venezuela) without historical GBS data available, we used the median rate For the comparison of sex and age groups, a Poisson regression model was also used to fit the cases per 100,000 population of GBS and Zika virus disease as the response variable and sex and age groups as categorical covariates. The ratio of the rates of GBS per 100,000 population by sex and age group, including 95% confidence intervals (95% CI) and p-values, were also calculated, using the youngest age group as a reference.
Zika virus disease, Dengue fever, Chikungunya, and GBS
In the Brazilian State of Bahia no cases of GBS were identified during a second peak of Zika virus disease in December 2015 (Figure 1a , Research Letter). There are at least two possible explanations. First, there GBS and Zika in the Americas were indeed cases of GBS, but they had not been reported by 31 March 2016. GBS is not a notifiable disease; and hospital discharges, including GBS cases, can be reported with delays of several months.
A second possibility is that the increased incidence of illness in December 2015 was not due to ZIKV but rather to another arbovirus, such as dengue or chikungunya. In Honduras, a similar pattern was observed. Circulation of dengue fever in previous years (2010) (2011) (2012) (2013) (2014) (2015) , especially an epidemic year in 2010, did not appear to result in a corresponding increase in the cases of GBS detected ( Figure S3 ). Furthermore, when dengue, zika, and GBS were plotted for the first 26 weeks of 2016, the peak of GBS coincided with the peak of Zika ( Figure S4 ). 
Patterns of Zika virus disease and Guillain-Barré syndrome by age and sex
Cases of Zika virus disease were reported by age and sex in Bahia State, Brazil, and in El Salvador. For GBS, age and sex data were available for Bahia State, Colombia, El Salvador, and Honduras. Sex was reported for 603 of the cases of GBS in these four settings, of which 55.2% were males. Table S1 shows the ratio of cumulative incidence of GBS and Zika virus disease, comparing the incidence among males and females. Among females, those aged 20-29, 30-39, and 40-49 years were reported to have the highest cumulative incidence of Zika virus disease, with 241 (95% CI 234 to 248), 271 (95% CI 263 to 279), and 266 (95% CI 257 to 274) cases per 100,000 population, respectively ( Figure S5a ). The reported incidence of Zika virus disease per 100,000 population among males did not vary systematically among age groups. The cumulative incidence of GBS during the period of Zika virus circulation increased with age for males and females, with males over 60 years having the highest rates at 1.88 cases of GBS (95% CI 1.46 to 2.37) per 100,000 population ( Figure S5b ). The incidence was also greater for males than females in all but one age class (30-39 years), and overall. Figure S4a . Reported total cases of Zika virus disease per 100,000 population (and CI 95%) by sex and age group in Bahia State (Brazil) and El Salvador. Figure S4b . Guillain Barré Syndrome (GBS) incidence per 100,000 population (and 95%CI) by gender and age group for the period of Zika virus circulation. Bahia state (Brazil), Colombia, El Salvador, and Honduras.
